Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AbbVie Inc. Director's Dealing 2015

Feb 11, 2015

29755_dirs_2015-02-11_2ce9adb2-6bad-467a-9bc9-005346fc5b9c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2015-02-09

Reporting Person: SALEKI-GERHARDT AZITA (SVP, Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-02-09 Common stock, $0.01 par value M 2250 $24.0731 Acquired 3168 Indirect
2015-02-09 Common stock, $0.01 par value F 1425 $56.90 Disposed 1743 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-02-09 Option (right to buy) $24.0731 M 2250 Disposed 2015-02-17 Common stock (2250) Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common stock, $0.01 par value 85828 Direct
Common stock, $0.01 par value 1738 Indirect

Footnotes

F1: Balance in the AbbVie Savings Program as of February 9, 2015.

F2: The reporting person disclaims beneficial ownership of all securities held by her spouse.